Could SARS-CoV-2 cause tauopathy?

Pratt, James; Lester, Evan; Parker, Roy

Pratt, James; Lester, Evan; Parker, Roy.

Pratt J; Department of Biochemistry, University of Colorado Boulder, Boulder, CO 80303, USA.
Lester E; Department of Biochemistry, University of Colorado Boulder, Boulder, CO 80303, USA.
Parker R; Department of Biochemistry, University of Colorado Boulder, Boulder, CO 80303, USA; Howard Hughes Medical Institute, University of Colorado Boulder, Boulder, CO 80303, USA; BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303, USA. Electronic address: roy.parker@colorado.edu.

Lancet Neurol ; 20(7): 506, 2021 07.

Article in English | MEDLINE | ID: covidwho-1272806

Subject(s)

COVID-19/complications; SARS-CoV-2/pathogenicity; Tauopathies/etiology; Tauopathies/immunology; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tauopathies / SARS-CoV-2 / COVID-19 Topics: Long Covid Limits: Humans Language: English Journal: Lancet Neurol Journal subject: Neurology Year: 2021 Document Type: Article Affiliation country: S1474-4422(21)00168-X

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google